000			01385 a2200373 4500
005			20250511175807.0
264		0	_c19920302
008			199203s 0 0 eng d
022			_a0007-0920
024	7		_a10.1038/bjc.1992.5 _2doi
040			_aNLM _beng _cNLM
100	1		_aWilbur, D W
245	0	0	_aChemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill. _h[electronic resource]
260			_bBritish journal of cancer _cJan 1992
300			_a27-32 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aEtoposide _xtherapeutic use
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
700	1		_aCamacho, E S
700	1		_aHilliard, D A
700	1		_aDill, P L
700	1		_aWeisenthal, L M
773	0		_tBritish journal of cancer _gvol. 65 _gno. 1 _gp. 27-32
856	4	0	_uhttps://doi.org/10.1038/bjc.1992.5 _zAvailable from publisher's website
999			_c1316772 _d1316772